Revolution Medicines, Inc. Common Stock Earnings Dividend

NSE: RVMD|

Stock price: $205.11

Earnings Summary

Revenue	$0Mn
Net Profits	$-644.37Mn
Net Profit Margins	-Inf%

Highlights

Revenue:

Revolution Medicines, Inc. Common Stock’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2026. On a quarterly growth basis, Revolution Medicines, Inc. Common Stock has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Revolution Medicines, Inc. Common Stock’s net profit fell -160.05% since last year same period to $-644.37Mn in the Q2 2026. On a quarterly growth basis, Revolution Medicines, Inc. Common Stock has generated -41.99% fall in its net profits since last 3-months.

Net Profit Margins:

Revolution Medicines, Inc. Common Stock’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2026. On a quarterly growth basis, Revolution Medicines, Inc. Common Stock has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Revolution Medicines, Inc. Common Stock post its latest quarter earnings

EPS Estimate Current Quarter	-2.34
EPS Estimate Current Year	-2.34

Highlights

EPS Estimate Current Quarter:

Revolution Medicines, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -2.34 - a -21.24% fall from last quarter’s estimates.

EPS Estimate Current Year:

Revolution Medicines, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -2.34.

Key Ratios

Key ratios of the Revolution Medicines, Inc. Common Stock post its Q2 2026 earnings

Earning Per Share (EPS)

-2.34

Highlights

Earning Per Share (EPS):

Revolution Medicines, Inc. Common Stock’s earning per share (EPS) fell -78.63% since last year same period to -2.34 in the Q2 2026. This indicates that the Revolution Medicines, Inc. Common Stock has generated -78.63% annual rate of fall in its earning per share (EPS) in the last 4 quarters.